The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cancer diagnosis, cancer treatment, and association with cardiovascular disease in older adults: Results from ASPREE.
 
Jaidyn Muhandiramge
No Relationships to Disclose
 
John Raymond Zalcberg
Stock and Other Ownership Interests - Amarin Corporation; Biomarin; Concert Pharmaceuticals; Frequency Therapeutics; Gilead Sciences; Madrigal Pharmaceuticals; Moderna Therapeutics; Novavax; Opthea; Orphazyme; Twist Bioscience; UniQure; Zogenix
Honoraria - Deciphera; Gilead Sciences; Halozyme; Merck Serono; Specialised Therapeutics; Targovax
Consulting or Advisory Role - 1Globe Health Institute; Center for Emerging & Neglected Diseases (CEND); Deciphera; FivePHusion; Genor BioPharma; Halozyme; Lipotek; Merck Serono; Merck Sharp & Dohme; Novotech; Revolution Medicines; Specialised Therapeutics; Targovax
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); IQvia (Inst); Medtronic (Inst); Merck Serono (Inst); MSD Oncology (Inst); Mylan (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Deciphera; Merck Serono; Merck Sharp & Dohme; Sanofi
 
Andrew Mark Haydon
Honoraria - Merck; Novartis; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; Merck; Novartis
 
Erica T. Warner
No Relationships to Disclose
 
Peter Gibbs
Honoraria - Amgen; Merck; MSD Oncology; Roche; SERVIER
Consulting or Advisory Role - Haystack Oncology
Research Funding - Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb/Sanofi (Inst); Merck Serono (Inst); Pierre Fabre (Inst); Roche (Inst); Roche Molecular Diagnostics (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Servier
 
Galina Polekhina
No Relationships to Disclose
 
G J. Van Londen
Employment - CancerSurvivorMD; GvanLondenMD
Leadership - CancerSurvivorMD; GvanLondenMD
Stock and Other Ownership Interests - CancerSurvivorMD; GvanLondenMD
Consulting or Advisory Role - bioTheranostics
 
Suzanne G Orchard
No Relationships to Disclose